Recently we reported that inhibition of PDC activity via enhanced expression of PDK2 contributes to the Warburg metabolic and malignant phenotype in human HNSCC; and inhibition of PDK2 lowers the phosphorylation of PDHα and reverts the Warburg metabolic and malignant phenotype [11]. Here, PDHA1 is linked to head and neck squamous cell carcinoma.